Por: CNN Health November 01, 2022
CNN — Pfizer says it has enough promising data on its respiratory syncytial virus, or RSV, vaccine designed to protect newborns that it will end enrollment in the study and submit for US Food and Drug Administration approval by the end of the year. RSV is a common respiratory virus that typically causes mild, cold-like symptoms, but it can cause serious illness, particularly in older adults and infants. Pfizer’s vaccine candidate is... + full article
Newsweek USA Health November 02, 2022
Pfizer announced positive trial results on Tuesday for a vaccine designed to help protect against the respiratory syncytial virus, or RSV, potentially setting up the company to have the first shot of its kind to be approved against the virus.The exact timeline for the vaccine... + más
Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS
Pfizer says study shows vaccinating pregnant women protects newborns from RSV | ABC7
Associated Press USA Business November 01, 2022
New research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals each fall.The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be... + más
RSV cases are surging this fall. Here’s what you need to know. | The Boston Globe
What’s behind worrying RSV surge in US children's hospitals? | Associated Press
WPLG Local 10 USA Health November 01, 2022
Strong RSV vaccine data lifts hopes after years of futility | ABC News
ABC7 USA Health November 01, 2022
New research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall.The preliminary results buoy hope that after decades of failure and frustration, vaccines... + más
Pfizer Says Its Maternal RSV Vaccine Can Protect Newborns From Severe Illness | NBC 6 South Florida
ABC News USA Health November 01, 2022
New research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall.The preliminary results buoy hope that after decades of failure and frustration, against RSV may... + más
Strong RSV vaccine data lifts hopes after years of futility | WPLG Local 10
10 WBNS USA Health November 01, 2022
NEW YORK — shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals each fall. The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be... + más
ABC News USA Life November 01, 2022
After decades of researching respiratory syncytial virus, an , scientists this week announced a major development in plans for a possible vaccine that could be available as soon as next year.Among very young children, particularly those [younger] than 6 months of age, we have a... + más
After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year | CNN
About iurex | Privacy Policy | Disclaimer |